A patient with type 2 diabetes mellitus presents with an HbA1c of 8.5%, elevated creatinine levels, microalbuminuria, and dyslipidemia. Which intervention should the nurse prioritize to address the patient's current condition?

A) Initiate a GLP-1 receptor agonist to improve glycemic control.

B) Increase the dose of the current statin to manage dyslipidemia.

C) Educate the patient on a low-sodium diet to protect renal function.

D) Refer the patient to a podiatrist for peripheral neuropathy management.

A patient with type 2 diabetes presents with an HbA1c of 8.5%, elevated creatinine levels, microalbuminuria, dyslipidemia, non-proliferative diabetic retinopathy, and peripheral neuropathy. Which intervention should the nurse prioritize to address the patient's current condition and prevent further complications?

B) Discuss the potential addition of a GLP-1 receptor agonist or SGLT2 inhibitor with the healthcare provider to optimize blood glucose levels.

A) Educate the patient on the importance of regular exercise and a balanced diet to improve glycemic control.

B) Discuss the potential addition of a GLP-1 receptor agonist or SGLT2 inhibitor with the healthcare provider to optimize blood glucose levels.

C) Schedule an immediate follow-up with an ophthalmologist to address the retinopathy findings.

D) Increase the dosage of the current statin therapy to further manage dyslipidemia.

A patient with type 2 diabetes and early nephropathy has been started on a GLP-1 receptor agonist and an SGLT2 inhibitor. She is experiencing difficulty adhering to her medication regimen. Which nursing intervention is most appropriate to address her concern and improve adherence?

A) Educate the patient about the potential benefits of each medication in relation to her diabetes management.

B) Suggest the patient reduce the number of medications by discontinuing the SGLT2 inhibitor.

C) Arrange a weekly medication administration schedule to simplify the regimen.

D) Advise the patient to take all medications at bedtime to minimize daytime side effects.

A patient with type 2 diabetes has been started on a GLP-1 receptor agonist, an SGLT2 inhibitor, and an ACE inhibitor. She expresses difficulty managing her complex medication regimen and concerns about potential side effects. Which nursing intervention is most appropriate to support this patient in maintaining adherence to her treatment plan?

C) Coordinate a medication review with the pharmacist to explore possible regimen simplifications.

A) Provide a detailed, written schedule for medication administration times.

B) Encourage the patient to take all medications at once to simplify the regimen.

C) Coordinate a medication review with the pharmacist to explore possible regimen simplifications.

D) Advise the patient to prioritize taking the medications she feels are most important.

A patient with type 2 diabetes presents with increased fatigue, dizziness, frequent urination, and dry mouth. Her HbA1c is 7.8%, and urine microalbumin is 40 mg/g. Considering these findings, which nursing intervention is most appropriate to prioritize in her care plan?

C) Review and adjust the patient's dietary intake and meal planning.

A) Increase physical activity to improve insulin sensitivity.

B) Educate the patient on recognizing symptoms of hypoglycemia.

C) Review and adjust the patient's dietary intake and meal planning.

D) Encourage the patient to monitor blood pressure daily.

A patient with type 2 diabetes presents with increased fatigue, dizziness, frequent urination, and dry mouth. Home glucose monitoring shows postprandial glucose spikes, and her HbA1c has increased to 7.8%. Which of the following interventions should the nurse prioritize to address the patient's postprandial hyperglycemia?

B) Educate the patient on carbohydrate counting and its impact on blood glucose levels.

A) Increase the dose of her long-acting insulin.

B) Educate the patient on carbohydrate counting and its impact on blood glucose levels.

C) Advise the patient to take her oral hypoglycemic agent 30 minutes before meals.

D) Suggest the patient consume more protein and fiber with meals to slow glucose absorption.

A patient with diabetes presents with improved postprandial glucose levels but reports symptoms of dry mouth, frequent urination, and mild peripheral edema. Her heart rate has increased, and her blood glucose occasionally spikes above 180 mg/dL. Considering these findings, what is the most appropriate nursing action to address the current symptoms and potential complications?

C) Advise the patient to increase fluid intake and monitor for signs of dehydration.

A) Increase the patient's insulin dosage to better control blood glucose spikes.

B) Educate the patient on the importance of consistent carbohydrate intake to prevent glucose variability.

C) Advise the patient to increase fluid intake and monitor for signs of dehydration.

D) Suggest reducing physical activity to prevent further increase in heart rate.

A patient with diabetes mellitus reports occasional dry mouth, frequent urination, and mild peripheral edema. Her home blood glucose logs show improved but still sporadic elevated readings. What is the most appropriate nursing action to address her current symptoms?

B) Encourage the patient to increase fluid intake to address potential dehydration and monitor for changes in edema.

A) Educate the patient on reducing carbohydrate intake further to manage blood glucose spikes.

B) Encourage the patient to increase fluid intake to address potential dehydration and monitor for changes in edema.

C) Advise the patient to limit physical activity to prevent further increases in heart rate and edema.

D) Suggest the patient use diuretics to manage peripheral edema and assess for improvement.

A patient with early-stage diabetic nephropathy and mild hypertension has been started on an ACE inhibitor. Which nursing intervention is most important to monitor after initiating this medication?

C) Assessing for signs of angioedema

A) Monitoring the patient's blood glucose levels closely

B) Checking the patient's blood pressure regularly

C) Assessing for signs of angioedema

D) Evaluating the patient's urinary output

A patient with newly diagnosed diabetic nephropathy is started on an ACE inhibitor. Which assessment finding would indicate that the medication is effective in preserving renal function?

C) A reduction in urine microalbumin levels

A) A decrease in serum potassium levels

C) A reduction in urine microalbumin levels

D) An increase in blood pressure

Diabetes - Nursing Case Study

Pathophysiology

• Primary mechanism: Insulin resistance occurs when cells in muscles, fat, and liver do not respond well to insulin, leading to decreased glucose uptake and increased blood glucose levels, common in Type 2 Diabetes.

• Secondary mechanism: Inadequate insulin secretion by pancreatic beta cells occurs due to their dysfunction or destruction, leading to insufficient insulin to lower blood glucose, typical in both Type 1 and Type 2 Diabetes.

• Key complication: Chronic hyperglycemia causes vascular damage, which can lead to complications such as neuropathy, nephropathy, and retinopathy, impacting patient quality of life and requiring ongoing management.

Patient Profile

Demographics:

62-year-old female, retired school teacher

History:

• Key past medical history: Diagnosed with Type 2 Diabetes 10 years ago, hypertension, hyperlipidemia

• Current medications: Metformin, Lisinopril, Atorvastatin, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Numbness and tingling in feet

• Key symptoms: Fatigue, blurred vision, increased thirst, frequent urination, occasional headaches

• Vital signs: Blood pressure 145/90 mmHg, heart rate 88 bpm, respiratory rate 20 breaths per minute, temperature 98.6°F, weight 180 lbs, height 5'5"

Section 1

New Diagnostic Results:

During her follow-up visit, the patient underwent a series of diagnostic tests to assess the extent of her diabetic complications. The HbA1c level returned at 8.5%, indicating suboptimal long-term blood glucose control. Additionally, a comprehensive metabolic panel revealed elevated creatinine levels at 1.4 mg/dL, pointing towards potential early-stage nephropathy. The urinalysis showed microalbuminuria, further supporting the suspicion of kidney involvement secondary to diabetes. A lipid panel also revealed dyslipidemia with an LDL level of 160 mg/dL, despite current statin therapy, suggesting the need for a more aggressive approach to lipid management.

The ophthalmologic exam was performed to evaluate the blurred vision complaint, which uncovered non-proliferative diabetic retinopathy with microaneurysms in both eyes. This finding highlights the importance of early detection and reinforces the need for regular ophthalmic evaluations. The numbness and tingling in her feet were further investigated through a monofilament test, which confirmed reduced sensation, suggesting peripheral neuropathy. These diagnostic results collectively indicate the progression of diabetic complications, necessitating a comprehensive review and potential adjustment of her diabetes management plan.

Given these findings, the healthcare team must now engage in clinical reasoning to prioritize interventions. The focus will be on optimizing glycemic control, potentially including the addition of a GLP-1 receptor agonist or SGLT2 inhibitor to her regimen. Additionally, the team should consider further intensifying antihypertensive therapy to protect renal function and revising lipid management strategies. Patient education on lifestyle modifications, including diet and exercise, will be crucial in addressing these interrelated conditions and preventing further complications. This integrated approach aims to stabilize the patient's condition and enhance her quality of life while minimizing future risks.

Section 2

Response to Interventions:

Following the adjustment in the patient's diabetes management plan, the healthcare team initiated treatment with a GLP-1 receptor agonist to improve glycemic control and potentially aid in weight management. Additionally, an SGLT2 inhibitor was introduced to further assist with glucose regulation and provide renal protection, given the early indications of nephropathy. The patient's antihypertensive regimen was intensified with the addition of an ACE inhibitor, aiming to reduce the progression of kidney damage and better control her blood pressure, which had been persistently elevated at 145/90 mmHg during recent visits. To address the dyslipidemia, the statin dosage was increased, and the patient was advised on dietary modifications to reduce LDL cholesterol levels.

Over the next few weeks, the patient participated in a structured diabetes education program, focusing on lifestyle changes including dietary adjustments and the introduction of a regular, moderate exercise routine. Follow-up assessments revealed a positive trend in several areas: her fasting blood glucose levels showed improvement, consistently ranging between 100-120 mg/dL, and her blood pressure readings decreased to an average of 130/85 mmHg. While the patient reported a slight reduction in numbness and tingling in her feet, she remained vigilant about foot care practices as advised. A repeat lipid panel demonstrated a decrease in LDL to 140 mg/dL, indicating partial success of the intensified lipid management strategy.

Despite these improvements, the patient experienced new challenges in maintaining adherence to the complex medication regimen, expressing concerns about managing multiple medications and potential side effects. This presents an opportunity for the healthcare team to explore strategies to simplify her regimen where possible, ensure understanding through medication reconciliation, and provide support to enhance adherence. The patient's journey highlights the necessity of ongoing assessment and adaptation of the management plan to accommodate her evolving needs and the dynamic nature of diabetes and its complications.

Section 3

New Complications

As the patient continued her diabetes management journey, she presented for a routine follow-up appointment, reporting increased fatigue and occasional dizziness over the past week. Upon further questioning, she mentioned experiencing more frequent urination and a persistent dry mouth, raising concerns about her current level of glycemic control. The clinical team conducted a comprehensive review of her recent home blood glucose monitoring logs, which indicated several readings above 180 mg/dL in the afternoons, suggesting possible issues with postprandial glucose spikes.

In response to these symptoms, a set of diagnostic tests was ordered. The laboratory results revealed an HbA1c level of 7.8%, slightly elevated from her previous 7.3%, indicating a need for further optimization of her diabetes management plan. Additionally, a urine microalbumin test showed a slight increase from her baseline, with a level of 40 mg/g, reinforcing the concern for ongoing nephropathy. While her blood pressure remained stable at 130/85 mmHg, and her lipid profile continued to improve, these new findings prompted a reconsideration of her current treatment regimen.

The healthcare team decided to adjust the timing and dosage of her medications to better address her postprandial hyperglycemia and minimize adverse effects. A consultation with a certified diabetes educator was also arranged to revisit her dietary habits and reinforce meal planning strategies that align with her medication schedule. This collaborative approach aims to mitigate the new complications and restore a more balanced glycemic control, ensuring the patient's treatment plan evolves alongside her changing clinical status.

Section 4

In the weeks following the adjustment to her diabetes management plan, the patient returned for a follow-up appointment, eager to discuss any changes in her symptoms and overall well-being. During the initial assessment, the patient reported some improvement in her postprandial glucose levels, with fewer episodes of dizziness and slightly reduced fatigue. However, she still experienced occasional dry mouth and frequent urination, indicating that further adjustments might be necessary. Her home blood glucose monitoring logs showed some improvement, with afternoon readings now averaging around 160 mg/dL, though sporadic spikes above 180 mg/dL persisted.

A physical examination revealed a mild increase in her heart rate, now at 92 beats per minute compared to her previous baseline of 78, suggesting a potential underlying issue such as dehydration or a stress response. The healthcare team also noted signs of mild peripheral edema in the lower extremities, which had not been present during previous visits. These findings raised concerns about her renal function and fluid balance, prompting additional laboratory tests to evaluate her current status more thoroughly.

The team decided to prioritize a more comprehensive assessment of her renal function, ordering a repeat urine microalbumin test and a complete metabolic panel. While awaiting these results, the patient was advised to increase her fluid intake and was educated on recognizing early signs of dehydration. The new findings and persistent symptoms highlighted the need for ongoing vigilance and possible further modification of her treatment plan, underscoring the importance of a dynamic approach to managing her diabetes and associated complications.

Section 5

In the days following her visit, the patient's new diagnostic results returned, shedding light on her current health status. The urine microalbumin test revealed elevated levels of albumin, suggesting the early stages of diabetic nephropathy despite previous efforts to optimize her diabetes management. This finding was corroborated by the complete metabolic panel, which showed a slight increase in serum creatinine and a decreased glomerular filtration rate (GFR) of 55 mL/min/1.73 m², indicating reduced renal function. Furthermore, her electrolyte panel revealed mild hyponatremia, with a sodium level of 133 mEq/L, likely influenced by her increased fluid intake and potential renal impairment.

Given these results, the healthcare team recognized the need to address her renal health more aggressively to prevent further decline. The team discussed the importance of blood pressure management, as hypertension is a critical factor in the progression of nephropathy. The patient was started on an ACE inhibitor to help preserve kidney function and reduce albuminuria, even though her blood pressure readings were only mildly elevated at 138/86 mmHg. This decision was made to leverage the renal protective benefits of the medication. The patient was also counseled on maintaining a low-sodium diet and the potential need for future dietary modifications to manage her electrolyte balance and support kidney health.

The patient’s case highlights the intricate connections between diabetes management and renal health, necessitating a multifaceted approach to prevent further complications. Her response to the introduction of an ACE inhibitor and dietary changes will be closely monitored, with follow-up appointments scheduled to assess the effectiveness of these interventions and to adjust the treatment plan as necessary. This proactive strategy aims to stabilize her renal function while continuing to refine her diabetes management, underscoring the importance of a personalized and evolving care plan.